Finnrick, an independent testing programme, publishes 65 assays for Paramount Peptides: 45 met its Purity focus threshold (at least 99.5% purity, no more than 35% dosage deviation) and 20 did not. Most recent assay 2 Feb 2026.
Paramount Peptides operates from US CA, listed by Finnrick as "Trading". Source: Finnrick, https://www.finnrick.com/vendors/paramount-peptides.
Finnrick-tested with mixed results. Tested across 8 peptide products with 65 total samples.
Paramount Peptides is listed as active. Finnrick Grade C. Finnrick avg score: 6.7/10 across 65 samples (8 products). Mixed quality — some products test well, others below average.
Paramount Peptides holds independent lab grade C, assigned across 65 graded samples, average score 6.7/10. That grade comes from an independent grader's own sampling, not from PeptideAtlas, and it describes the samples that grader obtained rather than every batch sold.
| Product | Assays | Result |
|---|---|---|
| Retatrutide | 12 | 11 passed, 1 failed |
| BPC-157 | 11 | 6 passed, 5 failed |
| Tirzepatide | 11 | 7 passed, 4 failed |
| CJC-1295 | 9 | 3 passed, 6 failed |
| Semaglutide | 9 | 9 passed, 0 failed |
| Ipamorelin | 7 | 6 passed, 1 failed |
| PT-141 | 3 | 2 passed, 1 failed |
| Survodutide | 3 | 1 passed, 2 failed |
Source: Finnrick, as published 2026-08-09. Pass and fail are Finnrick's classification against its own threshold, not ours.
| Status | Active |
|---|---|
| Independent lab grade | C (65 samples) |
| Average grader score | 6.7/10 |
| Vendor type | Research-use supplier |
| Satisfaction | 0.4/5 |
|---|---|
| Delivery | 4.2/5 |
| Customer service | 4.4/5 |
| Packaging | 4/5 |
| Ease of purchase | 4.5/5 |
| Payment | 4/5 |
Scored out of 5 by the same independent grader, from its own buyers rather than from this site.
These details were read from Paramount Peptides's own website on 2026-08-10. Pages consulted:
Paramount Peptides is listed as active and we hold 65 Finnrick assays (45 passing, 20 failing its purity threshold); an independent lab grade of C. That is evidence about the batches that were tested or published, not a guarantee about the vial you receive.
Yes. Finnrick, an independent testing programme, publishes 65 assays for Paramount Peptides: 45 met its Purity focus threshold (at least 99.5% purity, no more than 35% dosage deviation) and 20 did not. Most recent assay 2 Feb 2026.
Similar vendors: Peptide Sciences, Limitless Life Nootropics, Polaris Peptides, NextechLabs, Yiwu Aozuo Trading Co, Shandong Shengyuan Peptide Technology, Bulk Peptide Supply, Skye Peptides.
Popular peptides: Semaglutide, Tirzepatide, Retatrutide, BPC-157, CJC-1295, Ipamorelin.
Other reviewed vendors: Particle Peptides Review, pct.zone Peptides Review, Peak Peptides Australia Review.